Fig. 2From: Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responsesSchematic of the prefusion intermediate of VSV G glycoprotein structure (left) (PDB 5I2M) [36] and of the HIV Env gp140 structure (right) (PDB 4ZMJ) [37] in juxtaposition to a membraneBack to article page